₩ 2840
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very poor margins and returns
Data is available to registered users only
Data is available to registered users only
About
iNtRON Biotechnology, Inc. is a global developer of biopharmaceutical solutions focused on averting and remedying human ailments. Its development efforts encompass a range of bacteriophage and endoricin-based therapeutics. This company, which has its primary operations in Seongnam-si, South Korea, was established in 1999.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.
Data is available to registered users only